
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited Operativer Cashflow 2011-2026 | QTNT
Operativer Cashflow Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -77.6 M | -80.6 M | -75.7 M | -68.4 M | -56.2 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -56.2 M | -80.6 M | -71.7 M |
Operativer Cashflow Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -89.2 M | -64.3 M | - | - | -96.2 M | -58.7 M | -32.1 M | - | -56.7 M | -30.6 M | -24.8 M | - | -64.8 M | -42.7 M | -25.1 M | - | -61.5 M | -41.1 M | - | - | - | -19.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -19.1 M | -96.2 M | -50.5 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-478 M | $ 17.01 | -0.12 % | $ 179 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 118.41 | 0.73 % | $ 36 B | ||
|
Medpace Holdings
MEDP
|
713 M | $ 427.96 | -0.55 % | $ 12.3 B | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 4.01 | -20.38 % | $ 371 M | ||
|
NeoGenomics
NEO
|
5.23 M | $ 8.9 | 0.51 % | $ 1.14 B | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
National Research Corporation
NRC
|
26.4 M | $ 17.96 | -4.16 % | $ 402 M | ||
|
Natera
NTRA
|
-432 M | $ 216.86 | 4.88 % | $ 21.3 B | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Personalis
PSNL
|
-45.2 M | $ 6.0 | 7.91 % | $ 356 M | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | $ 52.93 | 0.02 % | $ 2.69 B | ||
|
CareDx, Inc
CDNA
|
42 M | $ 20.96 | 1.26 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 1.61 | 1.26 % | $ 2.14 M | ||
|
Thermo Fisher Scientific
TMO
|
7.82 B | $ 473.89 | 1.54 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
13.2 M | $ 0.6 | -0.22 % | $ 61.9 M | ||
|
Castle Biosciences
CSTL
|
64.9 M | $ 25.04 | 1.77 % | $ 696 M | ||
|
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 59.41 | 4.78 % | $ 3.55 B | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 184.56 | -0.45 % | $ 9.15 B | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Waters Corporation
WAT
|
653 M | $ 348.79 | 1.76 % | $ 20.8 B | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
21.1 M | $ 15.05 | 1.01 % | $ 455 M | ||
|
Guardant Health
GH
|
-185 M | $ 92.61 | 3.45 % | $ 11.6 B | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
1.29 B | $ 123.81 | 2.05 % | $ 10.2 B | ||
|
Illumina
ILMN
|
837 M | $ 141.88 | 2.02 % | $ 22.6 B | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 5.38 | 7.6 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 2.01 | 0.1 % | $ 8.89 M | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.22 | 1.6 % | $ 5.1 M | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 85.47 | -0.41 % | $ 5.77 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 257.38 | 0.09 % | $ 21.4 B | ||
|
Celcuity
CELC
|
-153 M | $ 139.45 | -1.58 % | $ 6.52 B | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 9.16 | -1.19 % | $ 1.99 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 189.95 | -0.47 % | $ 21.1 B |